Quantum-Si incorporated (NASDAQ:QSI) Director Jonathan M. Rothberg Sells 3,506,267 Shares

Quantum-Si incorporated (NASDAQ:QSI) Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction on Friday, December 27th. The stock was sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the transaction, the director now directly owns 1,250,000 shares of the company’s stock, valued at approximately $4,175,000. This represents a 73.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Quantum-Si Stock Performance

Shares of QSI opened at $2.70 on Thursday. Quantum-Si incorporated has a 1 year low of $0.61 and a 1 year high of $4.14. The company has a market cap of $385.33 million, a price-to-earnings ratio of -4.22 and a beta of 3.20. The firm has a fifty day moving average of $1.29 and a 200-day moving average of $1.08.

Hedge Funds Weigh In On Quantum-Si

Several hedge funds and other institutional investors have recently modified their holdings of QSI. Bank of New York Mellon Corp raised its stake in shares of Quantum-Si by 3.5% during the second quarter. Bank of New York Mellon Corp now owns 322,460 shares of the company’s stock valued at $339,000 after purchasing an additional 10,811 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Quantum-Si during the second quarter valued at about $25,000. SG Americas Securities LLC bought a new stake in shares of Quantum-Si during the third quarter valued at about $53,000. Green Alpha Advisors LLC raised its stake in shares of Quantum-Si by 35.4% during the third quarter. Green Alpha Advisors LLC now owns 175,055 shares of the company’s stock valued at $154,000 after purchasing an additional 45,796 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of Quantum-Si by 210.5% during the third quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after purchasing an additional 133,438 shares in the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on QSI shares. Canaccord Genuity Group decreased their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th. HC Wainwright lifted their price objective on shares of Quantum-Si from $4.00 to $5.50 and gave the stock a “buy” rating in a report on Thursday, November 21st.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.